Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients

Background: The treat-to-target approach was recently adopted for psoriatic arthritis (PsA) management. Objective: To assess the implementation of the “treat-to-target” (T2T) concept in daily management of PsA by use of composite scores of disease activity versus clinical judgement alone. Methods: A...

Full description

Bibliographic Details
Main Authors: Tal Gazitt, Muhanad Abu Elhija, Amir Haddad, Idit Lavi, Muna Elias, Devy Zisman
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/23/5659
_version_ 1797507664880599040
author Tal Gazitt
Muhanad Abu Elhija
Amir Haddad
Idit Lavi
Muna Elias
Devy Zisman
author_facet Tal Gazitt
Muhanad Abu Elhija
Amir Haddad
Idit Lavi
Muna Elias
Devy Zisman
author_sort Tal Gazitt
collection DOAJ
description Background: The treat-to-target approach was recently adopted for psoriatic arthritis (PsA) management. Objective: To assess the implementation of the “treat-to-target” (T2T) concept in daily management of PsA by use of composite scores of disease activity versus clinical judgement alone. Methods: A total of 117 PsA patients from a longitudinal PsA cohort were enrolled consecutively in the study during each patient’s first clinic visit during 2016–2017. Clinic notes from the treating rheumatologist were reviewed by an independent rheumatologist, noting clinical impression of disease activity, treatment changes based on clinical judgement, and rationale. Treatment changes were then compared to the use of formal disease activity parameters in Minimal Disease Activity (MDA) and Disease Activity Index for Psoriatic Arthritis (DAPSA) composite measures. All associations were assessed using the chi-square test or the Mann–Whitney test, as appropriate. Results: The 117 PsA patient cohort consisted of 65.5% women, mean age 58.4 ± 13.6 years. Clinical judgement of treating rheumatologist concorded with MDA and DAPSA in 76 (65.5%) and 74 (64.9%) patients, respectively. Agreement between clinical judgement and composite measure criteria did not correlate with patient age, sex, alcohol/tobacco use, or treatment regimens chosen. Disagreement between physician assessment and MDA occurred in 40 (34.5%) cases: in 30 cases, the MDA status was overestimated due to disregard of patient reported outcomes (PRO), while underestimation of MDA status occurred in 25% of cases with treatment changes made in patients with a single active joint or enthesis. Underestimation of disease activity using DAPSA occurred in 22 cases and could be attributed to disregarding tender joint count, patient pain visual analogue scale and C-reactive protein level. Conclusion: In our cohort, agreement between clinical impression and formal composite measure utilization for implementation of T2T strategy occurred in 65% of patients. Discordance resulted from physicians’ overlooking PRO and emphasizing objective findings when using clinical judgement alone.
first_indexed 2024-03-10T04:51:42Z
format Article
id doaj.art-ca60a387188445eaa0bcde4c70d88038
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T04:51:42Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-ca60a387188445eaa0bcde4c70d880382023-11-23T02:37:34ZengMDPI AGJournal of Clinical Medicine2077-03832021-11-011023565910.3390/jcm10235659Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis PatientsTal Gazitt0Muhanad Abu Elhija1Amir Haddad2Idit Lavi3Muna Elias4Devy Zisman5Rheumatology Unit, Carmel Medical Center, Haifa 3436212, IsraelRheumatology Unit, Carmel Medical Center, Haifa 3436212, IsraelRheumatology Unit, Carmel Medical Center, Haifa 3436212, IsraelDepartment of Community Medicine and Epidemiology, Carmel Medical Center, Haifa 3436212, IsraelRheumatology Unit, Carmel Medical Center, Haifa 3436212, IsraelRheumatology Unit, Carmel Medical Center, Haifa 3436212, IsraelBackground: The treat-to-target approach was recently adopted for psoriatic arthritis (PsA) management. Objective: To assess the implementation of the “treat-to-target” (T2T) concept in daily management of PsA by use of composite scores of disease activity versus clinical judgement alone. Methods: A total of 117 PsA patients from a longitudinal PsA cohort were enrolled consecutively in the study during each patient’s first clinic visit during 2016–2017. Clinic notes from the treating rheumatologist were reviewed by an independent rheumatologist, noting clinical impression of disease activity, treatment changes based on clinical judgement, and rationale. Treatment changes were then compared to the use of formal disease activity parameters in Minimal Disease Activity (MDA) and Disease Activity Index for Psoriatic Arthritis (DAPSA) composite measures. All associations were assessed using the chi-square test or the Mann–Whitney test, as appropriate. Results: The 117 PsA patient cohort consisted of 65.5% women, mean age 58.4 ± 13.6 years. Clinical judgement of treating rheumatologist concorded with MDA and DAPSA in 76 (65.5%) and 74 (64.9%) patients, respectively. Agreement between clinical judgement and composite measure criteria did not correlate with patient age, sex, alcohol/tobacco use, or treatment regimens chosen. Disagreement between physician assessment and MDA occurred in 40 (34.5%) cases: in 30 cases, the MDA status was overestimated due to disregard of patient reported outcomes (PRO), while underestimation of MDA status occurred in 25% of cases with treatment changes made in patients with a single active joint or enthesis. Underestimation of disease activity using DAPSA occurred in 22 cases and could be attributed to disregarding tender joint count, patient pain visual analogue scale and C-reactive protein level. Conclusion: In our cohort, agreement between clinical impression and formal composite measure utilization for implementation of T2T strategy occurred in 65% of patients. Discordance resulted from physicians’ overlooking PRO and emphasizing objective findings when using clinical judgement alone.https://www.mdpi.com/2077-0383/10/23/5659psoriatic arthritisassessmentdisease activitycomposite disease activity measurespatient-reported outcomes
spellingShingle Tal Gazitt
Muhanad Abu Elhija
Amir Haddad
Idit Lavi
Muna Elias
Devy Zisman
Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
Journal of Clinical Medicine
psoriatic arthritis
assessment
disease activity
composite disease activity measures
patient-reported outcomes
title Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_full Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_fullStr Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_full_unstemmed Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_short Implementation of the Treat-to-Target Concept in Evaluation of Psoriatic Arthritis Patients
title_sort implementation of the treat to target concept in evaluation of psoriatic arthritis patients
topic psoriatic arthritis
assessment
disease activity
composite disease activity measures
patient-reported outcomes
url https://www.mdpi.com/2077-0383/10/23/5659
work_keys_str_mv AT talgazitt implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT muhanadabuelhija implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT amirhaddad implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT iditlavi implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT munaelias implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients
AT devyzisman implementationofthetreattotargetconceptinevaluationofpsoriaticarthritispatients